These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28285942)

  • 1. Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats.
    Carey LM; Lee WH; Gutierrez T; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG
    Neuroscience; 2017 May; 349():303-317. PubMed ID: 28285942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics.
    Lee WH; Xu Z; Ashpole NM; Hudmon A; Kulkarni PM; Thakur GA; Lai YY; Hohmann AG
    Neuropharmacology; 2015 Oct; 97():464-75. PubMed ID: 26071110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors.
    Smith AE; Xu Z; Lai YY; Kulkarni PM; Thakur GA; Hohmann AG; Crystal JD
    Behav Brain Res; 2016 May; 305():23-9. PubMed ID: 26909849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD.
    Li LP; Dustrude ET; Haulcomb MM; Abreu AR; Fitz SD; Johnson PL; Thakur GA; Molosh AI; Lai Y; Shekhar A
    Transl Psychiatry; 2018 Aug; 8(1):155. PubMed ID: 30108200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model.
    Sun Z; Meng P; Su C; Ji S; Gao Y; Wang H; Tian J; Li C
    Toxicol Appl Pharmacol; 2021 Oct; 429():115698. PubMed ID: 34428447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability.
    Lee WH; Carey LM; Li LL; Xu Z; Lai YY; Courtney MJ; Hohmann AG
    Mol Pain; 2018; 14():1744806918801224. PubMed ID: 30157705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABA
    Li J; Zhang L; Xu C; Shen YY; Lin YH; Zhang Y; Wu HY; Chang L; Zhang YD; Chen R; Zhang ZP; Luo CX; Li F; Zhu DY
    Theranostics; 2021; 11(12):5970-5985. PubMed ID: 33897893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of PSD95-nNOS protein-protein interactions decreases morphine reward and relapse vulnerability in rats.
    Oliva I; Saberi SA; Rangel-Barajas C; Iyer V; Bunner KD; Lai YY; Kulkarni PM; Garai S; Thakur GA; Crystal JD; Rebec GV; Hohmann AG
    Addict Biol; 2022 Sep; 27(5):e13220. PubMed ID: 36001441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupting nNOS-PSD95 Interaction Improves Neurological and Cognitive Recoveries after Traumatic Brain Injury.
    Qu W; Liu NK; Wu X; Wang Y; Xia Y; Sun Y; Lai Y; Li R; Shekhar A; Xu XM
    Cereb Cortex; 2020 Jun; 30(7):3859-3871. PubMed ID: 31989159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. nNOS-PSD95 interactions activate the PKC-ε isoform leading to increased GluN1 phosphorylation and the development of neuropathic mechanical allodynia in mice.
    Choi SR; Han HJ; Beitz AJ; Lee JH
    Neurosci Lett; 2019 Jun; 703():156-161. PubMed ID: 30926374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain.
    Wang W; Mei XP; Wei YY; Zhang MM; Zhang T; Wang W; Xu LX; Wu SX; Li YQ
    Brain Behav Immun; 2011 Oct; 25(7):1355-66. PubMed ID: 21496481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and action of cyclic GMP-dependent protein kinase Ialpha in inflammatory hyperalgesia in rat spinal cord.
    Tao YX; Hassan A; Haddad E; Johns RA
    Neuroscience; 2000; 95(2):525-33. PubMed ID: 10658633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of nNOS-NOS1AP protein-protein interactions suppresses neuropathic pain in mice.
    Lee WH; Li LL; Chawla A; Hudmon A; Lai YY; Courtney MJ; Hohmann AG
    Pain; 2018 May; 159(5):849-863. PubMed ID: 29319606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and up-regulation of spinal cord nitric oxide receptor, soluble guanylate cyclase, after formalin injection into the rat hind paw.
    Tao YX; Johns RA
    Neuroscience; 2002; 112(2):439-46. PubMed ID: 12044461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting PSD95-nNOS interaction by Tat-N-dimer peptide during status epilepticus is neuroprotective in MAM-pilocarpine rat model.
    Colciaghi F; Nobili P; Cipelletti B; Cagnoli C; Zambon S; Locatelli D; de Curtis M; Battaglia GS
    Neuropharmacology; 2019 Jul; 153():82-97. PubMed ID: 31047919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat.
    Sherwin E; Lennon A; Harkin A
    Int J Neuropsychopharmacol; 2017 Oct; 20(10):833-843. PubMed ID: 28977524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCγ signaling pathway.
    Huang YN; Tsai RY; Lin SL; Chien CC; Cherng CH; Wu CT; Yeh CC; Wong CS
    Behav Brain Res; 2012 Apr; 229(2):401-11. PubMed ID: 22309983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents.
    Florio SK; Loh C; Huang SM; Iwamaye AE; Kitto KF; Fowler KW; Treiberg JA; Hayflick JS; Walker JM; Fairbanks CA; Lai Y
    Br J Pharmacol; 2009 Sep; 158(2):494-506. PubMed ID: 19732061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal injection of the peptide myr-NR2B9c attenuates bone cancer pain via perturbing N-methyl-D-aspartate receptor-PSD-95 protein interactions in mice.
    Liu Y; Cui X; Sun YE; Yang X; Ni K; Zhou Y; Ma Z; Gu X
    Anesth Analg; 2014 Jun; 118(6):1345-54. PubMed ID: 24842180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
    Chapman V; Buritova J; Honoré P; Besson JM
    J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.